Hangzhou Just Biotherapeutics (Just China) raised $35M Series B venture round, led by Hillhouse Capital.
This funding round does not have an about section yet.
| Investor | Firm Type |
|---|
| Partner |
|---|
| Private Equity | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$35M
Top Valuation
-
Hangzhou Just Biotherapeutics (Just China) raised $35M in a Series B round.
The round was announced on 06/06/18.
The round was led by Hillhouse Capital.